Browsing Tag
vasomotor symptoms
2 posts
Can cendifensine shift prescribing behavior in menopause management?
Can cendifensine reshape menopause prescribing trends? Discover how Noema Pharma AG’s strategy could influence treatment decisions.
May 3, 2026
Millendo Therapeutics begins human trial of VMS drug candidate MLE-301
Millendo Therapeutics has started a phase 1 clinical trial of its selective neurokinin 3 receptor (NK3R) antagonist MLE-301,…
September 24, 2020